Total Payments
$2,014
2024 Payments
$552.06
Companies
14
Transactions
59
Medicare Patients
624
Medicare Billing
$35,039
Payment Breakdown by Category
Food & Beverage$2,014 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,014 | 59 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $713.61 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $206.84 | 5 | $0 (2024) |
| Lilly USA, LLC | $188.50 | 5 | $0 (2024) |
| Abbott Laboratories | $172.80 | 3 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $139.17 | 2 | $0 (2023) |
| Esperion Therapeutics, Inc. | $124.98 | 1 | $0 (2021) |
| Grifols USA, LLC | $117.17 | 1 | $0 (2024) |
| Amgen Inc. | $83.47 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $82.72 | 1 | $0 (2022) |
| Novo Nordisk Inc | $75.13 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $552.06 | 13 | ABBVIE INC. ($211.90) |
| 2023 | $621.06 | 17 | ABBVIE INC. ($205.05) |
| 2022 | $592.61 | 20 | ABBVIE INC. ($282.17) |
| 2021 | $247.90 | 9 | Esperion Therapeutics, Inc. ($124.98) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.60 | General |
| 10/10/2024 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $117.17 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: VACCINE | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.89 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Inflammation | ||||||
| 03/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Diabetes | ||||||
| 01/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Inflammation | ||||||
| 11/08/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 11/04/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $28.66 | General |
| 10/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Inflammation | ||||||
| 09/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Diabetes | ||||||
| 08/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Inflammation | ||||||
| 07/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $98.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 282 | 354 | $39,643 | $13,770 |
| 2022 | 8 | 151 | 178 | $22,900 | $8,141 |
| 2021 | 4 | 93 | 162 | $7,998 | $4,849 |
| 2020 | 3 | 98 | 112 | $24,513 | $8,280 |
Total Patients
624
Total Services
806
Medicare Billing
$35,039
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 123 | $26,199 | $8,708 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $4,872 | $2,227 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,592 | $1,005 | 38.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 11 | 11 | $814.00 | $319.11 | 39.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 26 | 30 | $375.00 | $252.00 | 67.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 23 | 24 | $1,320 | $248.40 | 18.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 16 | 18 | $630.00 | $236.16 | 37.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 14 | 14 | $770.00 | $230.44 | 29.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 21 | 22 | $528.00 | $167.42 | 31.7% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 14 | 19 | $437.00 | $150.29 | 34.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 20 | 28 | $560.00 | $87.08 | 15.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 12 | 13 | $312.00 | $73.58 | 23.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 12 | 13 | $234.00 | $66.04 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 63 | $13,419 | $4,764 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 28 | $4,032 | $1,398 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $3,016 | $1,299 | 43.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 12 | 14 | $490.00 | $185.19 | 37.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 11 | 11 | $605.00 | $182.93 | 30.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 12 | 13 | $715.00 | $135.37 | 18.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 14 | 15 | $360.00 | $115.03 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 21 | $262.50 | $62.16 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 47 | $4,465 | $2,799 | 62.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 21 | $2,835 | $1,822 | 64.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 16 | 16 | $464.00 | $150.72 | 32.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 12 | 78 | $234.00 | $76.55 | 32.7% |
About Monica Eccles
Monica Eccles is a Nurse Practitioner healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2019. The National Provider Identifier (NPI) number assigned to this provider is 1134683071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Monica Eccles has received a total of $2,014 in payments from pharmaceutical and medical device companies, with $552.06 received in 2024. These payments were reported across 59 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,014).
As a Medicare-enrolled provider, Eccles has provided services to 624 Medicare beneficiaries, totaling 806 services with total Medicare billing of $35,039. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Tucson, AZ
- Active Since 01/24/2019
- Last Updated 01/24/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1134683071
Products in Payments
- VRAYLAR (Drug) $627.81
- FREESTYLE LIBRE 2 (Device) $172.80
- MOUNJARO (Drug) $170.00
- QUVIVIQ (Drug) $139.17
- TEZSPIRE (Biological) $125.00
- NEXLIZET (Drug) $124.98
- HyperRAB (Biological) $117.17
- UBRELVY (Drug) $85.80
- Otezla (Drug) $83.47
- TRELEGY ELLIPTA (Drug) $82.72
- COLOGUARD DNA CAPTURE REAGENTS (Device) $42.72
- Ozempic (Drug) $41.62
- Rybelsus (Drug) $33.51
- FARXIGA (Drug) $20.91
- GARDASIL (Biological) $19.31
- EMGALITY (Drug) $18.50
- Vascepa (Drug) $17.52
- SOLIQUA 100/33 (Biological) $15.32
- ELIQUIS (Drug) $14.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Tucson
Sandra Kurtin, Np, NP
Nurse Practitioner — Payments: $175,218
Nurse Practitioner $175,218
Shannon Morgenstern, Np, NP
Nurse Practitioner — Payments: $46,213
Nurse Practitioner $46,213
America Ramirez Sierra, Np, NP
Nurse Practitioner — Payments: $18,869
Nurse Practitioner $18,869
Hillary Campbell, Aprn, APRN
Nurse Practitioner — Payments: $12,595
Nurse Practitioner $12,595
Svetlana Burtman, Fnp-C, FNP-C
Nurse Practitioner — Payments: $10,213
Nurse Practitioner $10,213
Kristina Trafelet, Fnp-C, FNP-C
Nurse Practitioner — Payments: $9,641
Nurse Practitioner $9,641